Cargando…
The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and a common cause of end-stage renal disease. Evaluation of a kidney biopsy is necessary for diagnosis, with routine immunofluorescence microscopy revealing dominant or co-dominant IgA immunodeposits usually with...
Autores principales: | Rizk, Dana V., Maillard, Nicolas, Julian, Bruce A., Knoppova, Barbora, Green, Todd J., Novak, Jan, Wyatt, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433978/ https://www.ncbi.nlm.nih.gov/pubmed/30941137 http://dx.doi.org/10.3389/fimmu.2019.00504 |
Ejemplares similares
-
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016) -
Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment
por: Knoppova, Barbora, et al.
Publicado: (2021) -
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
por: Reily, Colin, et al.
Publicado: (2018) -
Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021) -
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)